Literature DB >> 2196816

A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro.

J P Caulfield1, A Hein, M E Rothenberg, W F Owen, R J Soberman, R L Stevens, K F Austen.   

Abstract

Hypodense eosinophils were obtained from two patients with the idiopathic hyperosinophilic syndrome (IHES), and hypodense eosinophils were derived by culturing normodense human eosinophils from control donors in the presence of endothelial cells alone, granulocyte/macrophage-colony-stimulating factor (GM-CSF) alone, or GM-CSF and fibroblasts. These eosinophils were examined ultrastructurally and stereologically for alterations in the volume density (Vv) of their electron-dense granules, the Vv of their lucent granules, the Vv of their lipid droplets, the numerical density of their granules with respect to cytoplasm (Nv), and the plasma membrane surface area-to-cell volume ratio (Sv) that might account for their decreased sedimentation density. The hypodense eosinophils that were obtained from the two patients with IHES exhibited a one-third reduction in granule Vv relative to normodense eosinophils from control donors, primarily because of a decrease in granule size. The culture-derived hypodense eosinophils exhibited 10% to 16% decreases in their granule Vv, significant increases in their lucent granules, and a approximately 7.5% decrease in their Sv. Calculation of the cell volume from cross-sectional area measurements showed that the eosinophils that had been cocultured with fibroblasts in the presence of GM-CSF increased their volume by approximately 15%. The eosinophils that had been cocultured with endothelial cells exocytosed some of their granules. In conclusion, a composite of factors including cell swelling, a decrease in the volume of the cytoplasm occupied by granules, and an increase in granule lucency contributes to the hypodense phenotype in vitro, but only cell swelling and hypogranulation are seen in cells from patients with IHES. The latter could reflect the response of 'primed' hypodense eosinophils in vivo to pertinent tissue ligands.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196816      PMCID: PMC1877686     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  A principle for counting tissue structures on random sections.

Authors:  E R WEIBEL; D M GOMEZ
Journal:  J Appl Physiol       Date:  1962-03       Impact factor: 3.531

2.  Studies on blood eosinophils. I. Patients with a transient eosinophilia.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.

Authors:  M A Vadas; J R David; A Butterworth; N T Pisani; T A Siongok
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

4.  The mechanisms which produce vacuolated and degranulated eosinophils.

Authors:  P C Tai; C J Spry
Journal:  Br J Haematol       Date:  1981-10       Impact factor: 6.998

5.  Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.

Authors:  L Prin; J Charon; M Capron; P Gosset; H Taelman; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

6.  Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities.

Authors:  C De Simone; G Donneli; D Meli; F Rosati; F Sorice
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia.

Authors:  L Prin; M Capron; A B Tonnel; O Bletry; A Capron
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

8.  Arachidonic acid incorporation by cytoplasmic lipid bodies of human eosinophils.

Authors:  P F Weller; A M Dvorak
Journal:  Blood       Date:  1985-05       Impact factor: 22.113

9.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia.

Authors:  I Winqvist; T Olofsson; I Olsson; A M Persson; T Hallberg
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

10.  Nile red: a selective fluorescent stain for intracellular lipid droplets.

Authors:  P Greenspan; E P Mayer; S D Fowler
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

View more
  8 in total

1.  Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8.

Authors:  Ho Jeong Na; Robert G Hamilton; Amy D Klion; Bruce S Bochner
Journal:  J Immunol Methods       Date:  2012-06-06       Impact factor: 2.303

Review 2.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 3.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

4.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 5.  Eosinophils in the 1990s: new perspectives on their role in health and disease.

Authors:  A J Wardlaw
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

6.  Freshly isolated and cultured human monocytes obtained by plasmapheresis kill schistosomula of Schistosoma mansoni.

Authors:  M Lehn; C P Chiang; H G Remold; J R Swafford; J P Caulfield
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

7.  Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro.

Authors:  P C Tai; L Sun; C J Spry
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

8.  Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool.

Authors:  M Triggiani; A Oriente; M C Seeds; D A Bass; G Marone; F H Chilton
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.